Nadav Kidron Net Worth & Insider Trades

Nadav Kidron - President and CEO, Oramed Pharmaceuticals Inc

As of March 16, 2023

What is Nadav Kidron's Net Worth?

The current estimated net worth of Oramed Pharmaceuticals Inc's President and CEO, Nadav Kidron, is estimated to be about $6.53M . Nadav Kidron owns about 1,179,098 units of Oramed Pharmaceuticals Inc common stock. In the last 16 years at Oramed Pharmaceuticals Inc, Nadav Kidron has sold an estimated value of $5.62M worth.

What is Nadav Kidron's Past Insider Trading?

Nadav Kidron's largest purchase order was 100,000 units , worth over $201K on March 15, 2023. Nadav Kidron's largest sale order was 220,000 units , worth over $4.42M on August 11, 2021. In total, Nadav Kidron has made about 24 transactions over 16 years of their time at Oramed Pharmaceuticals Inc. Nadav Kidron usually trades in February, with the busiest year in 2021. The most recent transaction was a purchase order of 26,000 units , worth over $53.01K on March 16, 2023.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Nadav Kidron's Salary in 2020?

As President and CEO of Oramed Pharmaceuticals Inc, Nadav Kidron has a total base salary of $305,840 . Nadav Kidron received compensation valued at about $688,700 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of a bonus of $70,000 , option awards of $299,506 , and other compensation of $13,354 .

What is Nadav Kidron's' Mailing Address?

  • Mailing address is 142 W. 57th St. New York NY 10019 NY

Oramed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm

What are Oramed Pharmaceuticals Inc's Past Insider Trades?

Oramed Pharmaceuticals Inc's most recent insider trade came on March 16, 2023 by Nadav Kidron who bought 26,000 units worth $53.01K . In the last 15 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.78M and bought an estimated value of $6.59M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Nadav Kidron, President and CEO,  Miriam Kidron, Chief Scientific Officer,  and Leonard Sank, Director .

ORAMED PHARMACEUTICALS INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...